Tuning polymer properties of non-covalent crosslinked PDMS by varying supramolecular interaction strength
Literature Information
Brigitte A. G. Lamers, Marcin L. Ślęczkowski, Fabian Wouters, Tom A. P. Engels, E. W. Meijer, Anja R. A. Palmans
Non-covalently crosslinked polymeric networks are promising materials towards sustainable and recyclable plastics. Here, we present the post-functionalization of poly(dimethyl siloxane) (PDMS) with supramolecular moieties, attached as grafts to the PDMS backbone, to obtain recyclable PDMS networks. We select three different supramolecular motifs that differ in interaction strength and investigate how these differences affect the dynamic behavior of the networks. The introduction of dinitrohydrazones (hydz), which afford weak supramolecular interactions by π-stacking, resulted in a viscous material at room temperature. Stronger self-association was achieved by the introduction of benzene-1,3,5-carboxamides (BTAs) and ureidopyrimidinones (UPys), which self-assemble via triple and quadruple hydrogen bonding, respectively. This resulted in a thermoplastic elastomeric material for BTA-based PDMS and brittle materials for Upy-based PDMS. Time- and temperature-dependent mechanical measurements reveal that the dynamic nature of the supramolecular bonds becomes slower upon increasing the interaction strength. The polymers are fully recyclable by solvation or compression molding without the loss of material properties. Thereby, by using one linear PDMS backbone, we demonstrate how fundamentally different material properties are obtained by changing the supramolecular interaction strength and type of non-covalent crosslinks. These molecular insights broaden the scope and application of PDMS-based sustainable materials.
Related Literature
Target 2035 – update on the quest for a probe for every protein
Susanne Müller, Suzanne Ackloo, Arij Al Chawaf, Hartmut Beck, Shaunna Beedie, Ulrich A. K. Betz, Gustavo Arruda Bezerra, Paul E. Brennan, David Brown, Peter J. Brown, Alex N. Bullock, Adrian J. Carter, Apirat Chaikuad, Mathilde Chaineau, Alessio Ciulli, Ian Collins, Jan Dreher, Kristina Edfeldt, Aled M. Edwards, Ursula Egner, Stephen M. Fuchs, Matthew D. Hall, Ingo V. Hartung, Alexander Hillisch, Stephen H. Hitchcock, Evert Homan, Natarajan Kannan, James R. Kiefer, Stefan Knapp, Milka Kostic, Stefan Kubicek, Andrew R. Leach, Sven Lindemann, Hisanori Matsui, Jordan L. Meier, Maurice Michel, Maxwell R. Morgan, Anke Mueller-Fahrnow, Dafydd R. Owen, Benjamin G. Perry, Saul H. Rosenberg, Kumar Singh Saikatendu, Cora Scholten, Sujata Sharma, Anton Simeonov, Michael Sundström, Matthew H. Todd, Claudia Tredup, Timothy M. Willson, Georg E. Winter
DOI: 10.1039/D1MD00228G
Cyclisation strategies for stabilising peptides with irregular conformations
Quynh Ngoc Vu, Reginald Young, Haritha Krishna Sudhakar, Tianyi Gao, Tiancheng Huang, Yaw Sing Tan, Yu Heng Lau
DOI: 10.1039/D1MD00098E
Retraction: MicroRNA-451 blockade promotes osteoblastic differentiation and skeletal anabolic effects by promoting YWHAZ-mediated RUNX2 protein stabilization
DOI: 10.1039/D1MD90001C
Synthesis and structure–activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment
William L. Neumann, Karin E. Sandoval, Shirin Mobayen, Mahsa Minaeian, Stephen G. Kukielski, Khush N. Srabony, Rafael Frare, Olivia Slater, Susan A. Farr, Michael L. Niehoff, Audrey Hospital, Maria Kontoyianni, A. Michael Crider, Ken A. Witt
DOI: 10.1039/D1MD00044F
Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators
Swagat Sharma, Lauren Lesiak, Christopher D. Aretz, Yu Du, Sushil Kumar, Nagsen Gautam, Yazen Alnouti, Nikilesh V. Dhuria, Yashpal S. Chhonker, C. David Weaver, Corey R. Hopkins
DOI: 10.1039/D1MD00129A
Recent developments on MOF-based platforms for antibacterial therapy
Yiwei Liu, Luyi Zhou, Ying Dong, Rui Wang, Ying Pan, Shuze Zhuang, Dong Liu, Jianqiang Liu
DOI: 10.1039/D0MD00416B
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
Deepender Kaushik, Arshpreet Kaur
DOI: 10.1039/D1MD00031D
The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria
Samantha J. Bann, Ross D. Ballantine, Stephen A. Cochrane
DOI: 10.1039/D0MD00413H
Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities
Katrien Van Bocxlaer, Simon L. Croft
DOI: 10.1039/D0MD00343C
You might also like
How should waste containing 6-Chloro-5-(2'-hydroxy-3'-methoxy-4-biphenylyl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione (CAS: 1346607-05-3) be handled?
Waste containing 6-Chloro-5-(2'-hydroxy-3'-methoxy-4-biphenylyl)-3-(3-methoxyphe...
What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?
(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...
What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?
The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...
Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?
Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...
Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?
N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...
Are there alternatives to [(4R,5R,6S)-5-hydroxy-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-4-yl]methyl dihydrogen phosphate (CAS: 39679-56-6) in synthesis?
Alternative reagents such as other phosphates or similar functional groups can b...
Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?
There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...
What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?
When handling Aluminium trihexadecanoate, it is important to use appropriate per...
What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?
(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...
Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?
Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...
Source Journal
Polymer Chemistry

Polymer Chemistry welcomes submissions in all areas of polymer science that have a strong focus on macromolecular chemistry. Manuscripts may cover a broad range of fields, yet no direct application focus is required.











-1,2-cyclohexanediamine structure N,N'-Bis[3-(2-methoxyphenyl)-2-hydroxybenzyl](1R,2R)-1,2-cyclohexanediamine structure](https://static.chemtradehub.com/structs/928/928769-12-4-a4f0.webp)


